The influence of skin microorganisms on cutaneous immunity

Nature Reviews Immunology

Volumn 16, Issue 6, 2016, Pages 353-366

  Belkaid, Yasmine ^a   Tamoutounour, Samira ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; APC PROTEIN; AROMATIC HYDROCARBON RECEPTOR; COLECALCIFEROL; INTERLEUKIN 17; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; BACTERIAL IMMUNITY; COMMENSALISM; DERMATITIS; DISEASE ASSOCIATION; GAMMA DELTA T LYMPHOCYTE; GENETIC PREDISPOSITION; HOMEOSTASIS; HOST RESISTANCE; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION CONTROL; INNATE IMMUNITY; LANGERHANS CELL; MEMORY T LYMPHOCYTE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SKIN DISEASE; SKIN FLORA; SKIN INFECTION; T LYMPHOCYTE; TISSUE REPAIR; TISSUE SPECIFICITY; ANIMAL; CYTOLOGY; DISEASE PREDISPOSITION; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNITY; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MICROBIOLOGY; MICROFLORA; SKIN; SKIN DISEASES;

ANIMALS; DISEASE SUSCEPTIBILITY; HOMEOSTASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY; IMMUNOMODULATION; MICROBIOTA; SKIN; SKIN DISEASES;

EID: 84971247648     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri.2016.48     Document Type: Review

References (142)

1. Buffie C. G, & Pamer E. G. Microbiota-mediated colonization resistance against intestinal pathogens. Nat. Rev. Immunol. 13, 790-801 (2013).
2. Belkaid Y, & Hand T. W. Role of the microbiota in immunity and inflammation. Cell. 157, 121-141 (2014).
3. Otto M. Staphylococcus epidermidis - The 'accidental' pathogen. Nat. Rev. Microbiol. 7, 555-567 (2009).
4. Ibrahim F, Khan T, & Pujalte G. G. Bacterial skin infections. Prim. Care. 42, 485-499 (2015).
5. Roberts N, & Horsley V. Developing stratified epithelia: lessons from the epidermis and thymus. Wiley Interdiscip. Rev. Dev. Biol. 3, 389-402 (2014).
6. Pasparakis M, Haase I, & Nestle F. O. Mechanisms regulating skin immunity and inflammation. Nat. Rev. Immunol. 14, 289-301 (2014).
7. Tong P. L, et al. The skin immune atlas: three-dimensional analysis of cutaneous leukocyte subsets by multiphoton microscopy. J. Invest. Dermatol. 135, 84-93 (2015).
8. Belkaid Y, & Segre J. A. Dialogue between skin microbiota and immunity. Science. 346, 954-959 (2014).
9. Mueller N. T, Bakacs E, Combellick J, Grigoryan Z, & Dominguez-Bello M. G. The infant microbiome development: mom matters. Trends Mol. Med. 21, 109-117 (2015).
10. PrabhuDas M, et al. Challenges in infant immunity: implications for responses to infection and vaccines. Nat. Immunol. 12, 189-194 (2011).
11. Oh J, Conlan S, Polley E. C, Segre J. A, & Kong H. H. Shifts in human skin and nares microbiota of healthy children and adults. Genome Med. 4, 77 (2012).
12. Si J, Lee S, Park J. M, Sung J, & Ko G. Genetic associations and shared environmental effects on the skin microbiome of Korean twins. BMC Genomics. 16, 992 (2015).
13. Scharschmidt T. C, & Fischbach M. A. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome. Drug Discov. Today Dis. Mech. 10, pii: e83 e89 (2013).
14. Bouslimani A, et al. Molecular cartography of the human skin surface in 3D. Proc. Natl Acad. Sci. USA 112, E2120-E2129 (2015).
15. Grice E. A, et al. Topographical and temporal diversity of the human skin microbiome. Science. 324, 1190-1192 (2009).
16. Costello E. K, et al. Bacterial community variation in human body habitats across space and time. Science. 326, 1694-1697 (2009).
17. Song S. J, et al. Cohabiting family members share microbiota with one another and with their dogs. eLife 2, e00458 (2013).
18. Lai Y, et al. Commensal bacteria regulate Toll-like receptor 3 dependent inflammation after skin injury. Nat. Med. 15, 1377-1382 (2009).
19. Naik S, et al. Compartmentalized control of skin immunity by resident commensals. Science. 337, 1115-1119 (2012).
20. Gallo R. L, & Hooper L. V. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12, 503-516 (2012).
21. Nagy I, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/.chemokines in human sebocytes. Microbes Infect. 8, 2195-2205 (2006).
22. Chehoud C, et al. Complement modulates the cutaneous microbiome and inflammatory milieu. Proc. Natl Acad. Sci. USA. 110, 15061-15066 (2013).
23. Verhulst N. O, et al. Composition of human skin microbiota affects attractiveness to malaria mosquitoes. PLoS ONE 6, e28991 (2011).
24. Zhang X, Crippen T. L, Coates C. J, Wood T. K, & Tomberlin J. K. Effect of quorum sensing by Staphylococcus epidermidis on the attraction response of female adult yellow fever mosquitoes, Aedes aegypti aegypti (Linnaeus) (Diptera: Culicidae), to a blood-feeding source. PLoS ONE 10, e0143950 (2015).
25. Naik S, et al. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 520, 104-108 (2015).
26. Iwasaki A, & Medzhitov R. Control of adaptive immunity by the innate immune system. Nat. Immunol. 16, 343-353 (2015).
27. Hall J. A, et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity. 29, 637-649 (2008).
28. Ivanov I. I, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 139, 485-498 (2009).
29. Volz T, et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL 10 producing dendritic cells and regulatory Tr1 cells. J. Invest. Dermatol. 134, 96-104 (2014).
30. Laborel-Preneron E, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis secretomes isolated from the skin microbiota of atopic children on CD4+ T cell activation. PLoS ONE 10, e0141067 (2015).
31. Skabytska Y, et al. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity. 41, 762-775 (2014).
32. Yockey L. J, et al. The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation. J. Invest. Dermatol. 133, 2714-2721 (2013).
33. Bantz S. K, Zhu Z, & Zheng T. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell Immunol. 5, pii: 202 (2014).
34. Zhang L. J, et al. Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science. 347, 67-71 (2015).
35. Abtin A, et al. Perivascular macrophages mediate neutrophil recruitment during bacterial skin infection. Nat. Immunol. 15, 45-53 (2014).
36. Otto M. Staphylococcus aureus toxins. Curr. Opin. Microbiol. 17, 32-37 (2014).
37. Murphy K. M. Transcriptional control of dendritic cell development. Adv. Immunol. 120, 239-267 (2013).
38. Malissen B, Tamoutounour S, & Henri S. The origins and functions of dendritic cells and macrophages in the skin. Nat. Rev. Immunol. 14, 417-428 (2014).
39. Merad M, Sathe P, Helft J, Miller J, & Mortha A. The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting. Annu. Rev. Immunol. 31, 563-604 (2013).
40. Hoeffel G, et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209, 1167-1181 (2012).
41. Haniffa M, Bigley V, & Collin M. Human mononuclear phagocyte system reunited. Semin. Cell Dev. Biol. 41, 59-69 (2015).
42. Bedoui S, et al. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells. Nat. Immunol. 10, 488-495 (2009).
43. Haniffa M, et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity. 37, 60-73 (2012).
44. Schlitzer A, et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL 17 cytokine responses. Immunity. 38, 970-983 (2013).
45. Vander Lugt B, et al. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat. Immunol. 15, 161-167 (2014).
46. Kolts R. L, Maki H. S, Kuehner M. E, Roberts R. C, & Sautter R. D. Enhanced streptokinase-induced thrombolysis using heparin in a rabbit model. J. Invest. Surg. 2, 431-436 (1989).
47. Tussiwand R, et al. Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses. Immunity. 42, 916-928 (2015).
48. Briseno C. G, Murphy T. L, & Murphy K. M. Complementary diversification of dendritic cells and innate lymphoid cells. Curr. Opin. Immunol. 29, 69-78 (2014).
49. Scharschmidt T. C, et al. A wave of regulatory T cells into neonatal skin mediates tolerance to commensal microbes. Immunity 43 1011-1021 (2015).
50. Hansen S, & Lehr C. M. Transfollicular delivery takes root: the future for vaccine design? Expert Rev. Vaccines. 13, 5-7 (2014).
51. Igyarto B. Z, et al. Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses. Immunity. 35, 260-272 (2011).
52. Kashem S. W, et al. Candida albicans morphology and dendritic cell subsets determine T helper cell differentiation. Immunity. 42, 356-366 (2015).
53. Kobayashi T, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 42, 756-766 (2015).
54. Kautz-Neu K, et al. Langerhans cells are negative regulators of the anti-Leishmania response. J. Exp. Med. 208, 885-891 (2011).
55. Martinez-Lopez M, Iborra S, Conde-Garrosa R, & Sancho D. Batf3 dependent CD103+ dendritic cells are major producers of IL 12 that drive local Th1 immunity against Leishmania major infection in mice. Eur. J. Immunol. 45, 119-129 (2015).
56. Brewig N, et al. Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes. J. Immunol. 182, 774-783 (2009).
57. Ng L. G, et al. Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog. 4, e1000222 (2008).
58. Seneschal J, Clark R. A, Gehad A, Baecher-Allan C. M, & Kupper T. S. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity. 36, 873-884 (2012).
59. Akbari M, et al. IRF4 in dendritic cells inhibits IL 12 production and controls Th1 immune responses against Leishmania major. J. Immunol. 192, 2271-2279 (2014).
60. Fabri M, et al. Vitamin D is required for IFN-γ- mediated antimicrobial activity of human macrophages. Sci. Transl Med. 3, 104ra102 (2011).
61. Riol-Blanco L, et al. Nociceptive sensory neurons drive interleukin 23 mediated psoriasiform skin inflammation. Nature. 510, 157-161 (2014).
62. Kashem S. W, et al. Nociceptive sensory fibers drive interleukin 23 production from CD301b+ dermal dendritic cells and drive protective cutaneous immunity. Immunity. 43, 515-526 (2015).
63. Ribeiro-Gomes F. L, Peters N. C, Debrabant A, & Sacks D. L. Efficient capture of infected neutrophils by dendritic cells in the skin inhibits the early anti-leishmania response. PLoS Pathog. 8, e1002536 (2012).
64. Shen W, et al. Adaptive immunity to murine skin commensals. Proc. Natl Acad. Sci. USA 111, E2977-E2986 (2014).
65. Scholz F, Badgley B. D, Sadowsky M. J, & Kaplan D. H. Immune mediated shaping of microflora community composition depends on barrier site. PLoS ONE 9, e84019 (2014).
66. Battaglia M, et al. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes. 55, 1571-1580 (2006).
67. Lehman H. Skin manifestations of primary immune deficiency. Clin. Rev. Allergy Immunol. 46, 112-119 (2014).
68. Rezaei N, de Vries E, Gambineri E, & Haddad E. in Stiehm's immune deficiencies. Chap. 1 (eds Sullivan E. K, & Stiehm E. R.) 3-59 (Academic, 2014).
69. Smeekens S. P, et al. Skin microbiome imbalance in patients with STAT1/STAT3 defects impairs innate host defense responses. J. Innate Immun. 6, 253-262 (2014).
70. Kong H. H, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 22, 850-859 (2012).
71. van Rensburg J. J, et al. The human skin microbiome associates with the outcome of and is influenced by bacterial infection. MBio 6, e01315-01315 (2015).
72. Belkaid Y, Piccirilo. A. C, Mendez S, Shevack E. Sacks D. L. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 420, 502-507 (2002).
73. Suffia I. J, Reckling S. K, Piccirillo C. A, Goldszmid R. S, & Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J. Exp. Med. 203, 777-788 (2006).
74. Dudda J. C, Perdue N, Bachtanian E, & Campbell D. J. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559-1565 (2008).
75. Godfrey V. L, Wilkinson J. E, & Russell L. B. X linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379-1387 (1991).
76. Sanchez Rodriguez R, et al. Memory regulatory T cells reside in human skin. J. Clin. Invest. 124, 1027-1036 (2014).
77. Belkaid Y, & Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Annu. Rev. Immunol. 27, 551-589 (2009).
78. Nosbaum A, et al. Cutting edge: regulatory T cells facilitate cutaneous wound healing. J. Immunol. 196, 2010-2014 (2016).
79. Chiu I. M, et al. Bacteria activate sensory neurons that modulate pain and inflammation. Nature. 501, 52-57 (2013).
80. Witherden D. A, Ramirez K, & Havran W. L. Multiple receptor-ligand interactions direct tissue-resident γd T cell activation. Front. Immunol. 5, 602 (2014).
81. Laggner U, et al. Identification of a novel proinflammatory human skin-homing Vγ9Vd2 T cell subset with a potential role in psoriasis. J. Immunol. 187, 2783-2793 (2011).
82. Gray E. E, Suzuki K, & Cyster J. G. Cutting edge: identification of a motile IL 17 producing γ T cell population in the dermis. J. Immunol. 186, 6091-6095 (2011).
83. Sumaria N, et al. Cutaneous immunosurveillance by self-renewing dermal γd T cells. J. Exp. Med. 208, 505-518 (2011).
84. Gray E. E, et al. Deficiency in IL 17 committed Vγ4+ γd T cells in a spontaneous Sox13 mutant CD45.1+ congenic mouse substrain provides protection from dermatitis. Nat. Immunol. 14, 584-592 (2013).
85. Ramirez-Valle F, Gray E. E, & Cyster J. G. Inflammation induces dermal Vγ4+ γT17 memory-like cells that travel to distant skin and accelerate secondary IL 17 driven responses. Proc. Natl Acad. Sci. USA. 112, 8046-8051 (2015).
86. Maher B. M, et al. Nlrp 3 driven interleukin 17 production by γT cells controls infection outcomes during Staphylococcus aureus surgical site infection. Infect. Immun. 81, 4478-4489 (2013).
87. Murphy A. G, et al. Staphylococcus aureus infection of mice expands a population of memory γd T cells that are protective against subsequent infection. J. Immunol. 192, 3697-3708 (2014).
88. Clark R. A, et al. The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 176, 4431-4439 (2006).
89. Carbone F. R. Tissue-resident memory T cells and fixed immune surveillance in nonlymphoid organs. J. Immunol. 195, 17-22 (2015).
90. Schenkel J. M, & Masopust D. Tissue-resident memory T cells. Immunity. 41, 886-897 (2014).
91. Mueller S. N, & Mackay L. K. Tissue-resident memory T cells: local specialists in immune defence. Nat. Rev. Immunol. 16, 79-89 (2016).
92. Watanabe R, et al. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci. Transl Med. 7, 279ra39 (2015).
93. Gebhardt T, et al. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10, 524-530 (2009).
94. Mueller S. N, Gebhardt T, Carbone F. R, & Heath W. R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31, 137-161 (2013).
95. Peters N. C, et al. Chronic parasitic infection maintains high frequencies of short-lived Ly6C+CD4+ effector T cells that are required for protection against re infection. PLoS Pathog. 10, e1004538 (2014).
96. Mackay L. K, et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl Acad. Sci. USA. 109, 7037-7042 (2012).
97. Shin H, & Iwasaki A. Generating protective immunity against genital herpes. Trends Immunol. 34, 487-494 (2013).
98. Owens P, Han G, Li A. G, & Wang X. J. The role of Smads in skin development. J. Invest. Dermatol. 128, 783-790 (2008).
99. Mackay L. K, et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294-1301 (2013).
100. Suffia I, Reckling S, Salay G, & Belkaid Y. A role for CD103 in Treg retention at site of Leishmania major infection. J. Immunol.174, 5444-5455 (2005).
101. Cyster J. G, & Schwab S. R. Sphingosine 1 phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
102. Zaid A, et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl Acad. Sci. USA. 111, 5307-5312 (2014).
103. Jiang X, et al. Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity. Nature. 483, 227-231 (2012).
104. Gebhardt T, et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature. 477, 216-219 (2011).
105. Ariotti S, et al. Tissue-resident memory CD8+ T cells continuously patrol skin epithelia to quickly recognize local antigen. Proc. Natl Acad. Sci. USA. 109, 19739-19744 (2012).
106. Zhang Q, et al. DOCK8 regulates lymphocyte shape integrity for skin antiviral immunity. J. Exp. Med. 211, 2549-2566 (2014).
107. Knickelbein J. E, et al. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV 1 reactivation from neuronal latency. Science. 322, 268-271 (2008).
108. Muller A. J, et al. CD4+ T cells rely on a cytokine gradient to control intracellular pathogens beyond sites of antigen presentation. Immunity. 37, 147-157 (2012).
109. Schenkel J. M, et al. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science. 346, 98-101 (2014).
110. Ariotti S, et al. T cell memory. Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert. Science. 346, 101-105 (2014).
111. Crosby E. J, Goldschmidt M. H, Wherry E. J, & Scott P. Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. PLoS Pathog. 10, e1003970 (2014).
112. Leyden J. J, Marples R. R, & Kligman A. M. Staphylococcus aureus in the lesions of atopic dermatitis. Br. J. Dermatol. 90, 525-530 (1974).
113. Gao Z, Tseng C. H, Strober B. E, Pei Z, & Blaser M. J. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS ONE 3, e2719 (2008).
114. Chalmers R. J, O'Sullivan T, Owen C. M, & Griffiths C. E. A systematic review of treatments for guttate psoriasis. Br. J. Dermatol. 145, 891-894 (2001).
115. Marples R. R, Heaton C. L, & Kligman A. M. Staphylococcus aureus in psoriasis. Arch. Dermatol. 107, 568-570 (1973).
116. Nakamura Y, et al. Staphylococcus d-Toxin induces allergic skin disease by activating mast cells. Nature. 503, 397-401 (2013).
117. Niebuhr M, et al. Staphylococcal α-Toxin is a strong inducer of interleukin 17 in humans. Infect. Immun. 79, 1615-1622 (2011).
118. Dastgheyb S. S, & Otto M. Staphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environments. Future Microbiol. 10, 1981-1995 (2015).
119. Ichinohe T, et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl Acad. Sci. USA. 108, 5354-5359 (2011).
120. Grice E. A, et al. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc. Natl Acad. Sci. USA. 107, 14799-14804 (2010).
121. Fitz-Gibbon S, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J. Invest. Dermatol. 133, 2152-2160 (2013).
122. Kang D, Shi B, Erfe M. C, Craft N, & Li H. Vitamin B12 modulates the transcriptome of the skin microbiota in acne pathogenesis. Sci. Transl Med. 7, 293ra103 (2015).
123. Barker J. N, et al. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J. Investigative Dermatol. 127, 564-567 (2007).
124. Brown S. J, et al. Prevalent and low-frequency null mutations in the filaggrin gene are associated with early-onset and persistent atopic eczema. J. Investigative Dermatol. 128, 1591-1594 (2008).
125. Natsuga K, Cipolat S, & Watt F. M. Increased bacterial load and expression of antimicrobial peptides in skin of barrier-deficient mice with reduced cancer susceptibility. J. Invest. Dermatol. 136, 99-106 (2016).
126. Di Meglio P, Villanova F, & Nestle F. O. Psoriasis. Cold Spring Harb. Perspect. Med. 4 (2014).
127. Hoste E, et al. Innate sensing of microbial products promotes wound-induced skin cancer. Nat. Commun. 6, 5932 (2015).
128. Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 486, 207-214 (2012).
129. Zeeuwen P. L, et al. Microbiome dynamics of human epidermis following skin barrier disruption. Genome Biol. 13, R101 (2012).
130. Hand T, & Belkaid Y. Microbial control of regulatory and effector T cell responses in the gut. Curr. Opin. Immunol. 22, 63-72 (2010).
131. Leung D. Y, Walsh P, Giorno R, & Norris D. A. A potential role for superantigens in the pathogenesis of psoriasis. J. Invest. Dermatol. 100, 225-228 (1993).
132. Reginald K, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin. Exp. Allergy. 41, 357-369 (2011).
133. Sims J. E, & Smith D. E. The IL 1 family: regulators of immunity. Nat. Rev. Immunol. 10, 89-102 (2010).
134. Donia M. S, & Fischbach M. A. Human microbiota. Small molecules from the human microbiota. Science. 349, 1254766 (2015).
135. Medema M. H, & Fischbach M. A. Computational approaches to natural product discovery. Nat. Chem. Biol. 11, 639-648 (2015).
136. Marples R. R, Downing D. T, & Kligman A. M. Control of free fatty acids in human surface lipids by Corynebacterium acnes. J. Invest. Dermatol. 56, 127-131 (1971).
137. Findley K, et al. Topographic diversity of fungal and bacterial communities in human skin. Nature. 498, 367-370 (2013).
138. Oh J, et al. Biogeography and individuality shape function in the human skin metagenome. Nature. 514, 59-64 (2014).
139. Conlan S, et al. Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-Associated isolates. Genome Biol. 13, R64 (2012).
140. Iwase T, et al. Staphylococcus epidermidis Esp inhibits Staphylococcus aureus biofilm formation and nasal colonization. Nature. 465, 346-349 (2010).
141. Sacks D, & Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858 (2002).
142. Krishna S, & Miller L. S. Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin. Immunopathol. 34, 261-280 (2012).